HOME >> BIOLOGY >> NEWS
NASA-inspired technology may help preserve women's future fertility after cancer treatment

PITTSBURGH, April 29 Using technology borrowed from the National Aeronautics and Space Administration (NASA), scientists at the University of Pittsburgh's McGowan Institute for Regenerative Medicine have taken the first steps toward successfully preserving ovarian tissue from rats and mice in culture, including immature egg follicles, according to a study in the current issue of the journal Tissue Engineering. Such techniques may prove to be valuable in protecting the fertility of a woman with cancer whose future childbearing potential is threatened by the very chemotherapy or radiation treatments necessary to save her life.

"While it is possible for ovaries to be removed and frozen before cancer treatment, there is currently no reliable way to generate mature eggs once the stored tissue is thawed," said Alan J. Russell, Ph.D., director of the McGowan Institute and senior author of the study. "Finding a safe, dependable way to produce healthy eggs from preserved ovaries will be a significant advance toward conserving fertility for cancer patients."

In the most recent study using ovarian tissue in rats and mice, University of Pittsburgh scientists focused their efforts on ovarian tissue structures, including immature eggs and follicles, the main functional portion of the ovary. Under normal circumstances, follicles remain dormant until triggered at puberty to cycle through several stages of development before reaching full maturity. Eggs are nurtured within the follicle. Once all the follicles are gone, ovaries fail and a woman enters menopause.

"We looked at using suspension culture systems to provide a uniform setting for follicles that is similar to the natural ovarian environment," said Dr. Russell, who also is professor of surgery at the University of Pittsburgh School of Medicine.

Custom-designed rotating wall vessels and orbiting test tubes were the suspension systems used, explained Elizabeth McGee, M.D., a study co-author
'"/>

Contact: Michele Baum
baummd@upmc.edu
412-647-3555
University of Pittsburgh Medical Center
29-Apr-2004


Page: 1 2 3

Related biology news :

1. Yale digital diagnostic technology is basis of new company, HistoRx Inc.
2. AACR applauds NCI initiative on nanotechnology
3. Rensselaer marks the opening of the center for biotechnology and interdisciplinary studies
4. New imaging technology at Joslin shown to detect early signs of type 1 diabetes
5. Researchers show how to assemble building blocks for nanotechnology
6. Jefferson Lab detector technology aids development of cystic fibrosis therapy
7. National Academies Advisory: Sept. 18-19 Nanotechnology Conference
8. New diagnostic technology helps justify earlier cataract surgery
9. New textbook introduces students to the foundations, applications of nanotechnology
10. UK biotechnology business plan competition now open to students in the US and Canada
11. The future of nanotechnology

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/12/2020)... SOUTHFIELD, Mich. (PRWEB) , ... August 11, 2020 ... ... Janssen R&D subsidiary based in Princeton, NJ, have entered into license agreements with ... discovery and development. Both Roche and J&J have annual Research and Development ...
(Date:8/7/2020)... SAN FRANCISCO (PRWEB) , ... August 06, 2020 ... ... the life sciences industry, is pleased to announce that Eric Chen and Jessica ... Vice President of Product Management & Strategy, respectively. , Eric Chen heads development ...
(Date:8/5/2020)... ... , ... Regenative Labs has received approval from the Centers for Medicare & ... first Wharton’s jelly allografts to be assigned a Q code and be approved for ... Wharton’s jelly allograft product to be recognized as a 361 HCT/P by CMS regulated ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 29, 2020 , ... Editas Medicine, Inc. (Nasdaq: ... advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene ... strategic partnership whereby Catalent will provide support for the development, manufacturing, and clinical ...
(Date:7/18/2020)... ... 16, 2020 , ... After research model surgery and catheter implantation, the long ... only the beginning of a successful study, while protecting and accessing the catheter or ... Head of Surgery from Envigo in a live webinar on ...
(Date:7/10/2020)... ... July 09, 2020 , ... PathSensors Inc., ... has expanded the company’s exclusive license to include clinical applications for CANARY™ ... market, focusing initially on the SARS-CoV-2 biosensor. CANARY’s™ fast and highly ...
(Date:7/1/2020)... ... 29, 2020 , ... MedShift , a leading medical ... many obstacles created as a result of COVID-19. As a provider at the ... practices and medical manufacturers by expanding access to device offerings, technology services, and ...
Breaking Biology Technology:
Cached News: